MARQUETTE UNIVERSITY COLLEGE OF NURSING Perceived Cognitive Changes During Breast Cancer Chemotherapy Linda Piacentine, PhD, ACNP Jiannan Zhang, BSN, RN.

Slides:

Advertisements

Similar presentations

Jane Bear-Lehman, PhD, OTR/L, FAOTA NYU Steinhardt/NYU College Of Dentistry NYU Alzheimer’s Disease Center April 9, 2014 SUPPORTED IN PART BY GRANT UL1.

Advertisements

Is Caregiver Depression Associated with Children’s ADHD Symptoms and Overall Functioning? Randi Scott SUMR Final Presentation August 07, 2008.

Postpartum Depression Younglee KIM, RN, PHN, MSN.

Efficacy of Dialectical Behavioral Therapy with Deaf Psychiatric Patients: Longitudinal Changes Amanda O’Hearn, Ph.D. University of Rochester School of.

Results from a randomised controlled trial evaluating Mindfulness-Based Stress Reduction in Women with stages 0 to III Breast Cancer Caroline Hoffman,

Acknowledgements Methods Veena A. Satyanarayana PhD, Susan Bradford BSEd, Arbi Ben Abdallah DES, Linda B. Cottler PhD, MPH, Washington University School.

The Effects of Increased Cognitive Demands on the Written Discourse Ability of Young Adolescents Ashleigh Elaine Zumwalt Eastern Illinois University.

University of Kansas Medical Center

Conclusions Male breast cancer survivors experience substantial symptoms Hormonal symptoms are prevalent in male breast cancer survivors; in men without.

Knowledge, Cancer Fatalism and Spirituality as Predictors of Breast Cancer Screening Practices for African American and Caucasian Women Staci T. Anderson,

PILOT STUDY TO EXAMINE THE EFFECTS OF ART THERAPY DURING CHEMOTHERAPY ON STRESS AND QUALITY OF LIFE IN PATIENTS WITH STAGE 3 COLON CANCER For Presentation.

 Abstract For women newly diagnosed with breast cancer, psychosocial distress may interfere with their ability to cope with cancer treatment. Nurses should.

Intimate Partner Abuse among Iraq, Afghanistan, and Vietnam Veterans: Cohort Differences & Associations with Military Experiences Andra L. Teten, Ph.D.

Differences in Patterns of Impairment, Psychiatric Comorbidity and Headache Beliefs in Migraine and Chronic Tension-type Headache Kathleen M. Romanek M.S.,

© Copyright, The Joint Commission 1 Update on the Joint Commission’s Substance Use (SUB) Core Measure: SUB-1 Alcohol Use Screening Celeste Milton, MPH,

Body Mass Index Changes in Prodromal Huntington Disease Nancy R. Downing, PhD, RN CANS September 13, 2012.

Overview of Phase I Data: Approach and Findings Gary Bess Associates April 15, 2009.

The Relationship Between Student Satisfaction with Learning Online and Cognitive Load 16 th Annual Sloan Consortium International Conference on Online.

Emergency Nurses’ Knowledge and Attitudes Regarding Pain Keri Dillon, BSN, RN, CEN; Virginia Morse, PhD, RN; Sharon Ward, MS, RN, CEN Introduction Purpose.

Physical Function and Fall Risk among Urban Community Dwelling Elders Arline Bohannon, MD Pamela Parsons, PhD Department of Internal Medicine Section of.

ASNR 2015 Poster# EP-19 Effect of Chemotherapy on Brain Structure and Cognition in Older Women with Breast Cancer: a Brain MRI Study 1 Bihong T. Chen MD.

Developed by Linda J. Redford, R.N., Ph.D University of Kansas Medical Center In collaboration with Aging Services of California, Sacramento, CA and the.

IntroductionDiscussion  Academic, mental health, behavioral, and social deficits in student adjustment are major causes of college attrition rates. 1.

® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.

INTRODUCTION Early after injury, persons with mild traumatic brain injury (TBI) have been shown to experience physical, cognitive, and emotional difficulties.

DEVELOPEMENT OF A HOLISTC WELLNESS MODEL FOR MANAGERS IN TERTIARY INSTITUTIONS Petrus Albertus Botha Tshwane University of Technology Polokwane Delivery.

The Kansas Communities That Care Survey Survey Development.

This article and any supplementary material should be cited as follows: Twamley EW, Jak AJ, Delis DC, Bondi MW, Lohr JB. Cognitive Symptom Management and.

Introduction Introduction Alcohol Abuse Characteristics Results and Conclusions Results and Conclusions Analyses comparing primary substance of abuse indicated.

Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.

Psychological Testing

Symptom Distress During Breast Cancer Chemotherapy Does Race Matter? Margaret Quinn Rosenzweig, PhD, FNP-BC,AOCNP Associate Professor University of Pittsburgh.

Janet H. Van Cleave PhD, RN1 Brian Egleston PhD2

NON PHARMACOLOGICAL THERAPY OF MENTAL IMAGERY AND RELAXATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT Poptsi Ε.,1,3, Κounti F.,1,3,Τsolaki, Μ. 1,2 1.

Women’s Health Academic Centre Impact of stressful life events on migrant women’s mental health and well-being Laura Nellums MSc, PhD Student Dr Stephani.

Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.

Table 2. Characterization of the Pubmed data base’s articles included in the sample Selene Cordeiro Vasconcelos et al. Psychiatrics Disorders in Crack.

CoRPS Center of Research on Psychology in Somatic diseases subjective cognitive functioning in patients with breast problems.

Symptom Severity, Attribution, & Preference for Assistance While Taking Chemotherapy or Targeted Agents Sandra Spoelstra, PhD, RN 1 ; Barbara Given, PhD,

Determining Preferences for Symptom Management Assistance For Those with Oral Anti-Cancer Treatment Sandra L. Spoelstra, PhD, RN GSA Annual Meeting New.

Lauren K Lietzau, BS Linda N Meurer, MD, MPH Bernadette Witzack, MPS Linda Cieslik, PhD Ramona Williams, MSW Syed Ahmed, MD, DrPH Development and Evaluation.

The Symptom Experience While Taking Oral Anti-Cancer Medication (Chemotherapy or Targeted Agents) S. Spoelstra, PhD, RN 1 ; B. Given, PhD, RN, FAAN 1 ;

Predictors of Functioning in Women with Fibromyalgia Syndrome (FMS) Alexa Stuifbergen, PhD, RN, FAAN Professor Dolores V.Sands Chair in Nursing Research.

The Reliability and Validity of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) in Persons with Post-Acute Traumatic Brain Injury (TBI)

CoRPS Center of Research on Psychology in Somatic diseases Chemotherapy, cognitive functioning and quality of life in breast cancer patients.

Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.

Menstrual History and Quality-of-Life Outcomes in Women With Node-Positive Breast Cancer Treated With Adjuvant Therapy on the NSABP B-30 Trial Patricia.

Brain Injury In Their Own Words Cynthia Boyer, Ph.D March 20, 2013.

Sensitivity and specificity of depression screening tools among adults with intellectual and developmental disabilities (I/DD) Sarah H Ailey PhD RNC Rush.

Parity and Post-traumatic Stress: A Preliminary Study Benjamin Reissman 1, Sharmilla Amirthalingam 1, Gabriella Deanne 1, Jackie Finik 1,2, Yoko Nomura,

Linda Searle Leach, PhD RN, NEA-BC, CNL, UCLA School of Nursing

DSM-5 Changes Increase ADHD Symptom Endorsement Among College Students

Patient Symptoms >=4

S. Spoelstra, PhD, RN Oncology Nursing Society

GENDER DIFFERENCES IN FIRST-TIME HOMELESS ADULTS*

Cognitive Changes in Myotonic Dystrophy

Conclusions- Discussion

FUNDING ACKNOWLEDGEMENT

Physical Activity Reductions in Male Veterans With Traumatic Brain Injury Karl F. Kozlowski 1,Greg Homish 1, Michelle Alt 2, Sarah Piwowarczyk 2, Kerry.

University of South Alabama Neurobehavioural Associates

84 Breast Cancer patients

Cognitive Disorders and Aging

Understanding and Managing “Chemo Brain” in Oncology Patients Sacred Heart University Bridgeport Hospital, Connecticut Christina Masciale, S.N. Hospital.

Feasibility and acceptability of an mHealth cognitive behavioral stress management intervention to ameliorate HIV-related fatigue Julie Barroso, PhD, ANP,

Implications for Nursing Practice Design and Methodology

Physical and Psychological Sequelae of Breast Cancer in Men

Stacy D. Sanford, PhD, Jennifer L

Frailty: Calculating quality and cost

Alexa Stuifbergen, PhD, RN, FAAN Heather Becker, PhD, Frank Perez, PhD

Improving cognitive function to improve diabetes self-management

Presentation transcript:

MARQUETTE UNIVERSITY COLLEGE OF NURSING Perceived Cognitive Changes During Breast Cancer Chemotherapy Linda Piacentine, PhD, ACNP Jiannan Zhang, BSN, RN Alan Bloom, PhD Judith F. Miller, PhD, RN, FAAN

MARQUETTE UNIVERSITY COLLEGE OF NURSING Chemobrain Cognitive deficits associated with chemotherapy –Reported by 15-50% –unknown severity and duration of decreased cognition –Cause of the phenomenon not understood Most common –Verbal and visual memory –Attention/concentration –Processing speed

MARQUETTE UNIVERSITY COLLEGE OF NURSING Study Aim To compare perceived cognitive ability (concentration/attention, fatigue, memory and language/word finding) among women who receive chemotherapy following surgery for breast cancer and healthy women

MARQUETTE UNIVERSITY COLLEGE OF NURSING Study Design/Methods Descriptive, longitudinal Four self-report instruments, administered prior to and after 4 cycles of chemotherapy Data analysis –Descriptive analysis of demographics –Repeated Measures Anova

MARQUETTE UNIVERSITY COLLEGE OF NURSING Instruments Functional Assessment of Cancer Therapy Cognitive Version (FACT-Cog) –50 items General well-being with Breast Module (FACT-B) –23 items Fatigue (FACIT-F) –13 items Beck Depression Inventory (BDI-II) –21 items

MARQUETTE UNIVERSITY COLLEGE OF NURSING Sample Description 11 women starting on chemotherapy -No metastasis -No previous chemo -No psych disorders or history of substance abuse -No previous traumatic brain injury 7 healthy women matched for age and education

MARQUETTE UNIVERSITY COLLEGE OF NURSING VariablesChemoHealthy Age (years) Age range (years) 46.2 (32-58) 48.3 (38-58) Percent Race-White Ethnicity-Hispanic Education (mean years) Sample Description

MARQUETTE UNIVERSITY COLLEGE OF NURSING Chemotherapy Regimen AdriamycinCytoxan5-FUTaxotereCarboplatinTaxolHerceptin 1 AC DDYY Y 2 TC Y Y 3 AC DDYY Y 4 FACYYY Y 5 ACYY Allergic 6 AC DDYY 7 YY YY 8 TC Y Y 9 AC DDYY Y 10 TCH YY Y 11 TC Y Y

MARQUETTE UNIVERSITY COLLEGE OF NURSING Results FACT-Cog ChemoHealthy T1T2T1T2 Mental Acuity 14.6 (1.44) 11.9 (3.26) * (1.77) 15.6 (0.79) Concentration 14.0 (1.55) 13.2 (1.99) 13.6 (2.64) 15.7 (0.49) * Memory # 25.8 (1.89) 22.7 (4.32) * 22.7 (4.63) 24.3 (3.62) Verbal Fluency # 23.6 (2.25) 19.1 (5.72) 24.5 (2.59) 24.8 (2.64) Functional 23.7 (1.74) 20.4 (5.52) *24.7 (2.58) 25.8 (2.40) Others comments 15.6 (0.92) 11.8 (4.40) *15.6 (0.54) Change 31.6 (2.91) 22.0 (12.51)*31.3 (5.22) (1.70) FACT-Cog148.8 (8.15)121.0 (33.42)*147.8 (12.30)156.8 (7.44) COGQ 28.8 (2.82)25.9 (5.81 0)29.14± (0.76) & Indicates chemo group n=10 # indicates healthy group n=6 * Indicates a within group change over time Shading indicates a group difference at a specific time point

MARQUETTE UNIVERSITY COLLEGE OF NURSING Results FACT-B ChemoHealthy T1T2T1T2 PWB20.6 (1.91)18.6 (3.17)*23.4 (0.79)23.00 (1.00 ) SWB17.9 (2.66)17.6 (2.42)15.4 (4.04)16.00(3.16) EWB19.8 (4.22)21.0 (3.03)22.4 (1.72)22.6 (1.27) FWB21.2 (4.67)20.3 (5.42)24.7 (3.77)26.00 (2.08) BCS & 17.9 (4.20)17.1 (3.78)19.3 (2.69)20.14 (2.61) FACT-B (20.74)112.8 (14.5) xxx FACT-B rev96.0 (16.38)95.0 (11.5)105.3 (10.90)107.7 (7.32) & Indicates number of participants in chemo group is 10 * Indicates a within group change over time Shading indicates a group difference at a specific time point

MARQUETTE UNIVERSITY COLLEGE OF NURSING Results FACIT-F ChemoHealthy T1T2T1T2 Fatigue42.3 (4.37)36.5 (8.87)*47.4 (5.32)48.1 (2.73) * Indicates a within group change over time Shading indicates a between group difference at a specific time point

MARQUETTE UNIVERSITY COLLEGE OF NURSING Results BDI-II ChemoHealthy T1T2T1T2 Becks7.8 (5.38)10.8 (6.74)1.2 (0.75)0.83 (1.60)

MARQUETTE UNIVERSITY COLLEGE OF NURSING Conclusions Pre-chemotherapy compared to after 4 cycles: –Cognitive impairment increases –Physical well-being decreases –Fatigue symptoms increase Healthy persons report less fatigue at both timepoints Healthy persons report less cognitive impairment compared to those who have had 4 cycles of chemotherapy

MARQUETTE UNIVERSITY COLLEGE OF NURSING Limitations Pilot study with small sample size Lack of control group with cancer but no chemotherapy Unable to assess prior to cancer diagnosis and surgery Highly educated women Incomplete data Cognitive tool in development

MARQUETTE UNIVERSITY COLLEGE OF NURSING Future Directions Compare data to imaging and qualitative data Larger sample size Cancer control group Supported in part by DOD grant BC086890, State of Wisconsin Breast Cancer Check-off Funds and Greater Milwaukee Foundation and MCW Cancer Center